Table 2.
Immunohistochemical Results
| AMI group | Control group | P | |
|---|---|---|---|
| CP-OMP-2 positivity | |||
| In the unaffected myocardium: | |||
| Cases (no., %) | 9/10 (90%) | 1/10 (30%) | 0.0003 |
| In the coronary tree: | |||
| Cases (no., %) | 10/10 (100%) | 3/10 (30%) | 0.001 |
| Coronary segments (no., %) | 60/110 (54.5%) | 7/55 (12.7%) | 0.0001 |
| Ruptured and vulnerable | |||
| Plaques (no., %) | 15/28 (53.6%) | 0/4 | 0.04 |
| Stable plaques (no., %) | 45/82 (54.9%) | 5/51 (9.4%) | 0.0001 |
| CP-HSP-60 positivity in the coronary tree | |||
| Cases (no., %) | 10/10 (100%) | 6/10 (60%) | 0.02 |
| Coronary segments (no., %) | 79/110 (71.8%) | 8/55 (14.6%) | 0.0001 |
| Plaque inflammation* (mean ± SEM) | 121.6 ± 12.4 | 37.3 ± 11.9 | 0.001 |
*
CD68- and CD3-positive cells × mm2.